Does taking low-dose aspirin (81 mg) cause urinary problems such as retention, urgency, frequency, or incontinence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Low-Dose Aspirin Does Not Cause Urinary Problems

Low-dose aspirin (81 mg daily) does not cause urinary retention, urgency, frequency, or incontinence in clinical practice. The available evidence demonstrates that aspirin at this dose has no clinically significant effect on renal function or urinary symptoms 1, 2.

Renal and Urinary Effects

Low-dose aspirin is a very weak inhibitor of renal prostaglandin synthesis and produces no clinically significant impact on renal function or blood pressure control 1. This distinguishes it fundamentally from higher-dose NSAIDs, which can impair renal prostaglandin activity and affect urinary function 1, 2.

  • At doses of 75-162 mg daily, aspirin does not meaningfully alter glomerular filtration or urine output in most patients 1, 2
  • While modest changes in renal function parameters can occasionally occur in older adults, these are generally subclinical and do not manifest as urinary symptoms 2
  • The mechanism of aspirin's antiplatelet effect (inhibition of thromboxane synthesis) operates independently of urinary tract function 1, 3

Drugs That Actually Cause Urinary Retention

Urinary retention is well-documented with anticholinergic drugs, opioids, alpha-adrenoceptor agonists, and certain other medications—but not with low-dose aspirin 4. Observational data suggest up to 10% of acute urinary retention episodes are medication-related, primarily involving:

  • Anticholinergic agents (antipsychotics, antidepressants, respiratory medications) 4
  • Opioids and anesthetics 4
  • Alpha-adrenoceptor agonists 4
  • Benzodiazepines and calcium channel antagonists 4

Low-dose aspirin does not appear in systematic reviews of drug-induced urinary retention 4.

Clinical Context: Aspirin and Urological Procedures

The urological literature confirms that low-dose aspirin can be safely continued during most urological procedures without increased bleeding risk, further supporting its lack of adverse urinary effects 5, 2.

  • Ureteroscopy can be performed while continuing aspirin therapy 5, 2
  • For patients with cardiac risk factors on low-dose aspirin alone, continuation through the perioperative period carries no increased risk of major bleeding 5
  • Only high-risk procedures like TURP or percutaneous nephrolithotomy require aspirin discontinuation, and this is due to bleeding concerns—not urinary function issues 5, 2

Monitoring Considerations

If initiating low-dose aspirin in older adults, baseline and 1-2 week follow-up assessment of renal function (serum creatinine, BUN) is reasonable, though clinically significant changes are uncommon 2. This monitoring is precautionary and relates to subclinical renal parameters rather than urinary symptoms.

Common Pitfalls to Avoid

  • Do not confuse low-dose aspirin with NSAIDs: Regular NSAIDs can affect renal prostaglandins and potentially contribute to urinary issues, but low-dose aspirin does not share this mechanism 1, 4
  • Do not attribute benign prostatic hyperplasia symptoms to aspirin: Urinary retention in elderly men is far more likely related to prostatic enlargement, anticholinergic medications, or other causes 4, 6
  • Do not discontinue aspirin for urinary symptoms: The cardiovascular benefits of aspirin in appropriate patients far outweigh any theoretical urinary concerns, which lack evidence 1, 7

References

1
Guideline

aspirin therapy in diabetes.

Diabetes Care, 2004

2
Guideline

Renal Effects and Peri‑operative Management of Low‑Dose Aspirin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Can codeine cause urinary retention?
How should I manage a 36-year-old patient with grade 2 peripheral edema and a one‑week history of acute urinary retention, who has not responded to oral spironolactone 50 mg, hydrochlorothiazide 50 mg, and furosemide 80 mg, with normal renal and cardiac function and blood pressure of 120/60 mmHg?
Can ipratropium nasal spray cause urinary retention or difficulty urinating?
Can diltiazem precipitate or worsen urinary retention, particularly in older men with benign prostatic hyperplasia?
Can ibuprofen and ciprofloxacin cause urinary retention?
What is the typical location and prognosis of a fusiform abdominal aortic aneurysm?
Does flecainide affect urinary function or cause urinary retention?
How long should an epinephrine (adrenaline) infusion be continued in a patient with anaphylaxis?
What are the causes of voiding dysfunction four months after aquablation?
In a patient with suspected Klinefelter syndrome whose initial karyotype is 46,XY, what does this result indicate and what further evaluations or management steps should be considered?
How should I interpret a hepatic function panel with normal albumin, normal total bilirubin, mildly elevated direct bilirubin, elevated alkaline phosphatase, normal alanine aminotransferase, aspartate aminotransferase, and gamma‑glutamyl transferase, what education and treatment are recommended, and does fasting affect these findings?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.